Po Wang

Publications

• Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. Miller S, Hallmayer J, Wang PW, Hill SJ, Johnson SL, Ketter TA. J Psychiatr Res. 2013; 47 (2): 252-8
• Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder. Miller S, Ittasakul P, Wang PW, Hill SJ, Childers ME, Rasgon N, Ketter TA. J Clin Psychopharmacol. 2012; 32 (6): 814-9
• Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients. Srivastava S, Wang PW, Hill SJ, Childers ME, Keller KL, Ketter TA. J Psychiatr Res. 2012; 46 (7): 920-6
• Gender-specific lipid profiles in patients with bipolar disorder. Vemuri M, Kenna HA, Wang PW, Ketter TA, Rasgon NL. J Psychiatr Res. 2011; 45 (8): 1036-41
• Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. Wang PW, Hill SJ, Childers ME, Chandler RA, Rasgon NL, Ketter TA. J Psychiatr Res. 2011; 45 (8): 1128-32
• Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions? Ketter TA, Citrome L, Wang PW, Culver JL, Srivastava S. Acta Psychiatr Scand. 2011; 123 (3): 175-89
• Divalproex extended-release in acute bipolar II depression. Wang PW, Nowakowska C, Chandler RA, Hill SJ, Nam JY, Culver JL, Keller KL, Ketter TA. J Affect Disord. 2010; 124 (1-2): 170-3
• Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. Rasgon NL, Kenna HA, Reynolds-May MF, Stemmle PG, Vemuri M, Marsh W, Wang P, Ketter TA. Bipolar Disord. 2010; 12 (5): 504-13
• Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: a controlled study. Srivastava S, Childers ME, Baek JH, Strong CM, Hill SJ, Warsett KS, Wang PW, Akiskal HS, Akiskal KK, Ketter TA. J Affect Disord. 2010; 125 (1-3): 27-34
• Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Brooks JO, Wang PW, Bonner JC, Rosen AC, Hoblyn JC, Hill SJ, Ketter TA. J Psychiatr Res. 2009; 43 (3): 181-8
• Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression. Brooks JO, Bonner JC, Rosen AC, Wang PW, Hoblyn JC, Hill SJ, Ketter TA. Psychiatry Res. 2009; 172 (3): 200-4
• Insulin resistance and hyperlipidemia in women with bipolar disorder. Stemmle PG, Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL. J Psychiatr Res. 2009; 43 (3): 341-3
• A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities. Chandler RA, Wang PW, Ketter TA, Goodwin GM. Acta Psychiatr Scand. 2008; 118 (1): 81-5
• Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study. Wang PW, Yang YS, Chandler RA, Nowakowska C, Alarcon AM, Culver J, Ketter TA. J Psychiatr Res. 2008; 42 (6): 451-7
• Improving the pedagogy associated with the teaching of psychopharmacology. Glick ID, Salzman C, Cohen BM, Klein DF, Moutier C, Nasrallah HA, Ongur D, Wang P, Zisook S. Acad Psychiatry. 2007 May-Jun; 31 (3): 211-7
• Enhanced creativity in bipolar disorder patients: a controlled study. Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA. J Affect Disord. 2007; 100 (1-3): 31-9
• Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individuals. Strong CM, Nowakowska C, Santosa CM, Wang PW, Kraemer HC, Ketter TA. J Affect Disord. 2007; 100 (1-3): 41-8
• Adjunctive aripiprazole in treatment-resistant bipolar depression. Ketter TA, Wang PW, Chandler RA, Culver JL, Alarcon AM. Ann Clin Psychiatry. 2006 Jul-Sep; 18 (3): 169-72
• Overweight and obesity in bipolar disorders. Wang PW, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Sagduyu K, Miyahara S, Ketter TA. J Psychiatr Res. 2006; 40 (8): 762-4
• Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. Brooks JO, Wang PW, Strong C, Sachs N, Hoblyn JC, Fenn R, Ketter TA. Bipolar Disord. 2006; 8 (3): 248-54
• Clinical use of carbamazepine for bipolar disorders. Wang PW, Ketter TA. Expert Opin Pharmacother. 2005; 6 (16): 2887-902
• Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. Ketter TA, Wang PW, Chandler RA, Alarcon AM, Becker OV, Nowakowska C, O'Keeffe CM, Schumacher MR. J Clin Psychiatry. 2005; 66 (5): 642-5
• Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. Nowakowska C, Strong CM, Santosa CM, Wang PW, Ketter TA. J Affect Disord. 2005; 85 (1-2): 207-15
• New medication treatment options for bipolar disorders. Ketter TA, Wang PW, Nowakowska C, Marsh WK. Acta Psychiatr Scand Suppl. 2004; (422): 18-33
• Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang Ys. J Psychiatr Res. 2004; 38 (1): 47-61
• New anticonvulsant medication uses in bipolar disorder. Wang PW, Ketter TA, Becker OV, Nowakowska C. CNS Spectr. 2003; 8 (12): 930-2, 941-7
• Safety of antidepressants in the elderly. Sommer BR, Fenn H, Pompei P, DeBattista C, Lembke A, Wang P, Flores B. Expert Opin Drug Saf. 2003; 2 (4): 367-83
• The diverse roles of anticonvulsants in bipolar disorders. Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang YS. Ann Clin Psychiatry. 2003; 15 (2): 95-108
• The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. Ketter TA, Wang PW. J Clin Psychiatry. 2003: 64 Suppl 3 15-20
• Gabapentin augmentation therapy in bipolar depression. Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA. Bipolar Disord. 2002; 4 (5): 296-301
• Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. Janenawasin S, Wang PW, Lembke A, Schumacher M, Das B, Santosa CM, Mongkolcheep J, Ketter TA. Bipolar Disord. 2002; 4 (5): 328-34
• Pharmacokinetics of mood stabilizers and new anticonvulsants. Wang PW, Ketter TA. Psychopharmacol Bull. 2002; 36 (1): 44-66
• Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies. Ketter TA, Wang PW. J Clin Psychiatry. 2002: 63 Suppl 3 21-5
• Biology and recent brain imaging studies in affective psychoses. Wang PW, Ketter TA. Curr Psychiatry Rep. 2000; 2 (4): 298-304